Clinical TrialsSearch results
Number of results: 976
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Randomized Phase III trial of Paclitaxel plus Cisplatin versus Paclitaxel plus Carboplatin in Stage IVB, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
- uterine cervical neoplasms
- Japan Clinical Oncology Group(JCOG)
- 2006-02-21
Other
- Phase II clinical trial of personalized peptide vaccination in patients with advanced/metastatic urotherial cancer failed to standard treatment
- Urotherial cancer
- Kurume University School of medicine, Department of Immunology
- 2009-04-10
Other
- Phase II clinical trial of personalized peptide vaccination in patients with advanced/metastatic urotherial cancer previously treated with M-VAC chemotherapy
- Urotherial cancer
- Kurume University School of medicine, Department of Immunology
- 2008-03-10
Other
- Phase 2 Study of Avelumab and Tuvusertib in aUC that has Progressed on Prior Anti-PD-(L)1 Therapy
- Urothelial Carcinoma
- Ishii Kyoko
- 2024-08-19
Completed
- A Global Expanded Access Program for Enfortumab Vedotin in Patients with Locally Advanced or Metastatic Urothelial Carcinoma (EV-902)
- Urothelial Carcinoma
- Steinberg Joyce
- 2021-05-18
Other
- Efficacy and Safety of Zoledronic acid on urological cancer patients with bone metastasis: a phase II clinical study.
- Urological Cancer with bone metastasis (Hormone resistant prostate cancer, Kidney cancer, urothelial cancer, kidney pelvis and ureteral cancer)
- Department of Urology, Graduate School of Medical Sciences, Kyushu University
- 2009-08-10
Other
- Phase 3 study of HPN-100 in Japanese patients with urea cycle disorder
- Urea cycle disorder
- Hiroiku Furukawa
- 2023-02-28
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18
Other
- A multicenter phase II open-label study in untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma evaluating efficacy and safety of maintenance therapy with IDEC-C2B8.
- Untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma.
- Zenyaku Kogyo Co., Ltd.
- 2008-12-26
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09